Pongamia pinnata (L.) Pierre leaf extract: in vitro, in vivo, and in silico approaches to combat the waterborne bacterial pathogens associated with diarrheal conditions.

Authors

Awadhesh Kumar, T B C Laldingliani, Rakesh Kumar, Nurpen Meitei Thangjam, Ramdinmawia Vuite, Sumanta Kumar Sahu, Ravi Rawat, Tapan Behl, Volkan Eyupoglu

Published in

Frontiers in cellular and infection microbiology. Volume 16. Pages 1830625. Epub Jul 20, 2026.

Abstract

Pongamia pinnata (L.) Pierre, a medicinal plant traditionally used in Indian ethnomedicine, was evaluated for its antidiarrheal, antibacterial, and antioxidant properties through a combination of in vitro, in vivo, and in silico approaches. This study aims to study the traditional use of plants in medicine and identify a suitable secondary metabolite that can help reduce bacterial growth in living systems, thereby lowering the risk of waterborne diseases and diarrhea. Screening of P. pinnata leaf extract confirmed the presence of various bioactive classes, including alkaloids, flavonoids, etc., and that it also had strong antioxidant activity. In vitro antibacterial assays revealed that the plant extract effectively inhibited multiple waterborne pathogens, particularly Shigella dysenteriae Castellani and Chalmers, 1919, and in vivo studies also showed significant dose-dependent antidiarrheal effects. Acute oral toxicity tests at high doses confirmed the extract's safety, with no adverse effects on body weight, behavior, or vital organs. GC-MS analysis revealed various secondary metabolites with N-decanoic acid as the most abundant in the plant extract. Notably, 1,2,5,6-di-O-isopropylidene-3-O-methanesulfonyl glucofuranose and spiro{2,4}heptane derivatives exhibited stronger binding affinities than the standard drug ampicillin in molecular docking studies with penicillin-binding proteins (PBPs). These findings suggest that P. pinnata harbors potent metabolites with significant antidiarrheal and antibacterial activity, offering promise for the development of plant-based therapeutics against waterborne bacterial pathogens. The integration of experimental and computational approaches strengthens its candidacy for future drug development targeting diarrheal diseases.

PMID:
42548598
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.